Point-of-care SARS-CoV-2 serological assays for enhanced case finding in a UK inpatient population
Abstract Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic. Case identification is currently made by real-time polymerase chain reaction (PCR) during the acute phase and largely restricted to healthcare laboratories. Serological assays are emerging but indepen...
Guardado en:
Autores principales: | S. J. C. Pallett, S. J. Denny, A. Patel, E. Charani, N. Mughal, J. Stebbing, G. W. Davies, L. S. P. Moore |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/18645fb8647b4c11a3c7678cd9e26f8d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays.
por: Zahra Rikhtegaran Tehrani, et al.
Publicado: (2020) -
Self-sampling of capillary blood for SARS-CoV-2 serology
por: Lottie Brown, et al.
Publicado: (2021) -
Application of SARS-CoV-2 Serology to Address Public Health Priorities
por: Amy C. Sherman, et al.
Publicado: (2021) -
A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies
por: Patthara Kongsuphol, et al.
Publicado: (2021) -
Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021
por: Asish Kumar Ghosh, et al.
Publicado: (2021)